Capital Market Strategies LLC Makes New $335,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Capital Market Strategies LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,639 shares of the financial services provider’s stock, valued at approximately $335,000. Other hedge funds also recently […]

Related Keywords

,Thompson Investment Management Inc ,Nasdaq ,Exchange Commission ,Red Lighthouse Investment Management ,Nasdaq Biotechnology Index Fund ,Vigilant Capital Management ,Lakewood Asset Management ,Wealthplan Partners ,Capital Market Strategies ,Shares Biotechnology ,Free Report ,Capital Management ,Investment Management ,Lighthouse Investment Management ,Shares Nasdaq Biotechnology ,Shares Nasdaq Biotechnology Index Fund ,Industry Classification Benchmark ,Ishares Biotechnology Etf ,Nasdaq Ibb ,Ibb ,Finance ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,